Balyasny Asset Management »

Nurix Therapeutics shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Nurix Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nurix Therapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nurix Therapeutics by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.1M 122k 9.24
2023-12-31 $233k 23k 10.32
2023-09-30 $207k 26k 7.86
2022-09-30 $208k 16k 13.06
2021-06-30 $2.1M 79k 26.53
2021-03-31 $1.4M 44k 31.09

More positions owned by Balyasny Asset Management

Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Tesla Motors Call Option (TSLA)
Select Sector Spdr Tr Financial (XLF)
Amazon Call Option (AMZN)
Meta Platforms Cl A Call Option (META)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vaneck Etf Trust Gold Miners Etf (GDX)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Visa Com Cl A Call Option (V)
Wolfspeed Common Stock (WOLF)

View all positions for Balyasny Asset Management

Top funds holding Nurix Therapeutics

FMR
BlackRock
Deep Track Capital
Vanguard Group
Baker Bros. Advisors
Commodore Capital
Redmile Group
Vestal Point Capital
Point72 Asset Management
State Street Corporation
Soleus Capital Management
Kynam Capital Management
Morgan Stanley
Pictet Asset Management Holding SA
Geode Capital Management

View all funds holding Nurix Therapeutics